The MarketWatch News Department was not involved in the creation of this content.

Sep 29, 2020 (AmericaNewsHour) —
Global Cancer Biomarkers Market was valued at USD 13.50 Billion in the year 2017. Global Cancer Biomarkers Market is further estimated to grow at a CAGR of 14% from 2019 to reach USD 37.94 Billion by the year 2025.
The Global Cancer Biomarkers is segmented as by cancer type, by profiling technology, by biomarkers, and by region. On the basis of the type of cancer the Market is segmented as Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Others of which breast cancer holds the highest Market share.

On the basis of Profiling Technology, the Global Cancer Biomarkers Market is segmented as OMICS Technology, Imaging Technology, Immunoassays, Cytogenetics, and Bioinformatics of which OMICS Technology is expected to hold the highest Market share in the forecasted period.

Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10078325

On the other hand, by a Biomarkers Type, the Market is segmented as Protein Biomarkers, Genetic Biomarkers and others for this protein biomarker segment are expected to grow at highest CAGR during the year 2019-2025. The large share of this segment is mainly attributed to the tremendous potential of protein biomarkers in cancer detection.

Major market players in Cancer Biomarkers Market are 23andMe, Agilent Technologies, Abbott Laboratories Inc., Biomerieux, Hologic Inc., Roche Holding AG, Illumina Inc., Roche Diagnostics, GE Healthcare, Bio-Rad Laboratories, and brief information of 10 companies will be provided in the report.

SWOT Analysis of Cancer Biomarkers Market:
Strength:
Increased Incidences of Cancer Globally
Higher Acceptance for Treatment in Developing Regions

Weakness:
High Cost of Diagnosis and Reimbursement Issues

Opportunities:
Technological and Scientific advancements
Emerging Economies

Threats:
Unfavorable Regulatory framework and policies

Cancer Biomarkers Market Segmentation:
By Cancer Type
*Prostate Cancer
*Breast Cancer
*Lung Cancer
*Colorectal Cancer
*Cervical Cancer
*Others

By Profiling Technology
*OMICS Technology
*Imaging Technology
*Immunoassays
*Cytogenetics
*Bioinformatics

By Biomarkers Type
*Protein Biomarkers
*Genetic Biomarkers
*Others

By Region
*North America
o USA
o Canada
*Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
*APAC
o China
o India
o Japan
o Rest of Asia-Pacific
*RoW
o Latin America
o Middle East & Africa

Get Complete Access of Study Report: https://www.kennethresearch.com/sample-request-10078325

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research
Email: [email protected]
Phone: +1 313 462 0609

The post Cancer Biomarkers Market Opportunities, Size, Share, Emerging Trends, Technological Innovation and Forecasts appeared first on America News Hour.

COMTEX_372046733/2606/2020-09-29T09:08:47

Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Source Article